UROGEN PHARMA LTD
URGN·M96088105·US·Common Stock·Healthcare - Biotechnology-Activist
URGN (UROGEN PHARMA LTD) is held by 111 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($167.2M), BlackRock, Inc. ($117.8M), MORGAN STANLEY ($94.8M). Net institutional sentiment: Mixed.
111
Holders
(8 Elite)
$920M
Total Value
66% (104)
Consensus
69 buying - 35 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 28, 2026 · Activists Aug 12, 2026 · Congress none
InsiderRJRobinson James A. Jr.Exercise 2K shAug 26, 2026
InsiderSMSchoenberg MarkSell $2.9MAug 20, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 118
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer